https://www.nature.com/articles/s41598-022-14601-3
Proven safe and tolerable in humans with very minimal side effects and not systematically absorbed. Virtually the same formula approved in Australia for prevention and treatment BV. Proven greater than 99% effective in a highly challenged humanised mouse model world health organisation approved trial at the world renowned Scripps Institute in the US. Prevents virus entering the brain possibly assisting to eliminate long Covid imo. Shortly we will have the results that are highly likely to provide irrefutable evidence that Australians should have been given access to this as soon as the tolerability study concluded. IMO the Aust Gov have likely been grossly negligent, bureaucracy got in the way, preventing the TGA to approve the use of Viraleze, in some capacity. A safe and cheap medical device that had a high probability would provide a level of extra preventative to its citizens for the greater good public health. They had nothing to loose. If it didn’t work no harm would have been done. It would be interesting to see it argued in an inquiry. Next few weeks will be very interesting. If the results are as good as all the anecdotal evidence available has suggested results should be, there would be a very good case to holding an inquiry imo. I think it would be found that SPL would be vindicated from a targeted campaign to undermine the science in favour for the promotion of profit to mask makers, hand sanitiser manufacturers and profits to vaccine monopolies. Starpharma shareholders will have have been robbed, should be outraged and should be compensated. Imo.
- Forums
- ASX - By Stock
- SPL
- Jeremy Paull Safety and Tolerability in humans
Jeremy Paull Safety and Tolerability in humans
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.6¢ | $35.40K | 364.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 365495 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 16718 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 365495 | 0.097 |
2 | 150000 | 0.095 |
2 | 110000 | 0.094 |
2 | 300667 | 0.093 |
2 | 525600 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 16718 | 1 |
0.105 | 56878 | 2 |
0.110 | 210058 | 7 |
0.115 | 109827 | 3 |
0.120 | 59907 | 7 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |